Endostim taps ex-Livanova neuromod head Hoare as new prez, CEO
Endostim said this week it appointed Rohan Hoare as its new president and chief executive officer, taking over for co-founder Bevil Hogg who will remain on to serve as a consultant.
“Dr. Hoare’s impressive executive leadership experience and his success in neuromodulation product development and commercialization make him the right person to lead EndoStim’s worldwide expansion. We are confident he will apply his unique vision to advancing our therapy, which has the potential to help millions of individuals suffering from severe gastroesophageal reflux disease,” Endostim board chair Doug French said in a prepared statement.